ABCG1 and acute lymphoblastic leukemia: Benzamil and taurocholate inhibit ABCG1 (Cserepes et al., 2004; Skarda et al., 2021), and our study reveals that benzamil treatment sensitizes Reh-MTXR cells to MTX, presenting a promising avenue for future ALL treatment.